首页/数据集/CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2

CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2

NIAID Data Ecosystem2026-05-02 收录

HIV-1逆转录酶耐药突变体结构

艾滋病药物设计

数据链接：

https://www.rcsb.org/structure/1JLC 数据链接链接失效反馈

官方服务：

资源简介：

CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2

应用场景：

创建时间：

2024-10-30

HIV药物分子结构

艾滋病药物设计

Crystal structure of HIV-1 reverse transcriptase (RT) in complex with 4-[(4-{4-[(E)-2-cyanoethenyl]-2,6-dimethylphenoxy}thieno[3,2-d]pyrimidin-2-yl)amino]-2-fluorobenzonitrile (24b), a non-nucleoside

Protein Data Bank Japan2023-10-11 更新50

HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY

艾滋病药物设计

蛋白酶抑制剂结构分析

HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY Descriptor: HIV-1 PROTEASE, [4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHEN

Protein Data Bank Japan2024-11-20 更新40

Candidate peptide inhibitors for HIV proteins.

艾滋病药物设计

抑制剂筛选

Note: a The peptide IDs are HIPdb ID; b The Mechanisms were the potential functions of the peptides reported in the previous studies [31]. Candidate peptide inhibitors for HIV proteins.

NIAID Data Ecosystem30

Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with TSAO-T, a non-nucleoside RT inhibitor (NNRTI)

艾滋病药物设计

蛋白酶-抑制剂复合物结构

Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with TSAO-T, a non-nucleoside RT inhibitor (NNRTI) Descriptor: 1-[(5R,6R,8R,9R)-4-amino-9-{[tert-butyl(dimethyl)silyl]oxy}-6-({[tert-bu

Protein Data Bank Japan2023-09-13 更新40

The RMSD between minimized and crystal structures of gp120.

蛋白质结构比对

艾滋病药物设计

The RMSD between minimized and crystal structures of gp120.

NIAID Data Ecosystem40